Topic
GLP-1 drugs
28 stories related to this topic, newest first.
israelnationalnews.comscience8 days ago
Study of 49 Telehealth Sites Finds Mixed Clinical Oversight for GLP-1 Weight-Loss Prescriptions
A Yale University researcher posing as a patient examined 49 websites prescribing GLP-1 drugs. The study, published Monday in JAMA, found many prescriptions were issued without appropriate clinical care.
world12 days ago
MassHealth Ends Medicaid Coverage of GLP-1 Drugs for Weight Loss
MassHealth will stop paying for GLP-1 medications prescribed solely for weight loss starting Friday. The change affects roughly 22,000 adults and 2,500 children enrolled in the state Medicaid program.
globalnews.capolitics14 days ago
Medicare Begins Temporary Coverage of GLP-1 Drugs for Obesity
A short-term pilot program allowing Medicare to cover GLP-1 medications for obesity treatment begins July 2 and runs through 2027. Beneficiaries will pay $50 monthly while manufacturers set a $245 price per drug. The program covers obesity treatment only and requires prior author…
theconservativetreehouse.comscience14 days ago
Trump Administration Sets $245 Monthly Price for GLP-1 Drugs in Medicare and Medicaid with $50 Copay Requirement
The November agreement with Eli Lilly and Novo Nordisk covered obesity indications previously excluded from Medicare. Coverage required private Medicare insurers to offer the drugs at a $50 copay.
agfundernews.combusiness16 days ago
David Protein Forecasts $300 Million Revenue as GLP-1 Drug Use Raises Both Protein Demand and Ingredient Costs
Founder Peter Rahal links the brand’s growth to the popularity of GLP-1 drugs that have reduced traditional diet trends. The company projects strong sales while whey prices rise sharply.
finance.yahoo.combusiness22 days ago
UPS to Spend $48 Million Upgrading 27 Temperature-Controlled Facilities
United Parcel Service will upgrade facilities across the Americas, Europe and Asia to handle temperature-sensitive shipments. The move targets expanding demand for biologics and GLP-1 drugs.
forbes.comscience24 days ago
Meta-analysis finds tirzepatide produced largest weight loss among three GLP-1 drugs
A University of Georgia review of 14,000 non-diabetic patients showed tirzepatide led to more than 20 percent body-weight reduction, compared with roughly 15 percent for semaglutide and 8 percent for liraglutide.
citizen.co.zascience27 days ago
GLP-1 Drugs Linked to Lower Violent Crime Rates in New Analysis
A social media post highlighted potential reductions in violent crime associated with GLP-1 drugs used for diabetes and obesity treatment. The observation follows documented benefits in other health areas beyond their approved uses.
ER
nypost.comworld27 days ago
Study Links GLP-1 Drugs to Reduced Impulsivity
A new study suggests GLP-1 medications may affect decision-making beyond appetite control. Research examined links between these drugs and behavior in people taking them.
yahoo.comscience30 days ago
NBER simulation finds GLP-1 drugs could cut lifetime medical costs but most health plans do not cover them for weight loss
A National Bureau of Economic Research simulation projects lifetime medical savings from sustained GLP-1 treatment for obesity. The study also notes that most health plans do not cover the drugs for weight loss.
Wiredtechnology33 days ago
Customers Report Unauthorized Charges From Telehealth Service Selling Compounded GLP-1 Drugs
Multiple users of FitRx and Zealthy, Inc. say they were charged for medication shipments they did not request. The company previously paid a $5 million settlement with the U.S. government over similar complaints.
Nprscience35 days ago
GLP-1 Drugs Linked to Lower Cancer Risk in Observational Studies, but Causation Unproven
Analyses presented at the May 2026 American Society of Clinical Oncology meeting found reduced cancer incidence and progression among patients taking GLP-1 obesity treatments.
qz.comscience36 days ago
Survodutide Achieves 13% Weight Loss and Up to 63% Liver-Fat Reduction in Phase 3 Trial, Trailing Existing GLP-1 Drugs
Patients lost 13 percent of body weight on the highest dose after 76 weeks. Liver-fat reduction exceeded placebo by a wide margin.
citizen.co.zascience38 days ago
GLP-1 Drugs Linked to Lower Mortality, Stroke in Obesity-Autoimmune Patients in Observational Study
A propensity-matched analysis of 26,408 people found GLP-1 drugs reduced mortality, stroke, pulmonary embolism, and emergency room visits.
ER
Nbc Newsscience38 days ago
Pfizer and Amgen Report Midstage Data on Experimental Monthly GLP-1 Drugs for Weight Loss
Pfizer and Amgen are advancing monthly GLP-1 drugs that could reduce injections from 52 to 12 per year. Early trial data show weight loss and blood-sugar control with side effects similar to weekly versions.
New York Postscience47 days ago
Study Links GLP-1 Drugs to Lower Cancer Progression in Four Types
A Cleveland Clinic analysis of 12,112 patients found lower rates of progression to stage 4 disease among those taking GLP-1 medications compared with DPP-4 inhibitors. The observational results will be presented at the 2026 ASCO Annual Meeting.
ncbi.nlm.nih.govscience53 days ago
GLP-1 Drug Effects on Cancer Remain Unresolved
Medical researcher Eric Topol stated that any potential link between GLP-1 drugs and cancer incidence is not yet confirmed. He noted that observed effects may relate to weight loss rather than independent mechanisms.
ER
forbes.comscience63 days ago
Oral Weight Loss Pill Orforglipron Helps Maintain Results After Injectable GLP-1 Drugs
Two randomized studies published in Nature Medicine show patients who switched from tirzepatide or semaglutide to daily oral orforglipron maintained 75 to 79 percent of their weight loss after one year, compared with 38 to 49 percent for those on placebo. The trial involved 376 p…
ER
activistpost.comscience80 days ago
Preliminary Evidence Links GLP-1 Drugs to Restrictive Eating Disorders
A medical journal has published preliminary evidence suggesting that GLP-1 drugs may exacerbate or lead to new cases of restrictive eating disorders. This includes conditions such as anorexia nervosa. The findings were highlighted in a recent report.
ER
thehindu.comscience94 days ago
New Oral GLP-1 Drugs Offer Maintenance Option for Weight Loss After Injections
Eli Lilly and Novo Nordisk have introduced oral versions of their GLP-1 receptor agonist drugs for weight management. These pills provide an alternative to weekly injections, with clinical data showing they help maintain weight loss. Side effects and costs remain similar to the i…
NA
Substrate placeholder — needs reviewscience95 days ago
FDA Withdraws Approval of GSK Drug; GLP-1 Generics Enter India Market; Estrogen Patches Face Shortage
The U.S. Food and Drug Administration withdrew approval for a GlaxoSmithKline drug previously promoted by the Trump administration for autism treatment. In India, generic versions of GLP-1 drugs are entering the obesity treatment market. A shortage of estrogen patches used for me…
ST
citizen.co.zafinance96 days ago
GLP-1 Weight Loss Drugs Drive Potential $13 Billion Boost in Apparel Retail Spending
Millions of individuals using GLP-1 drugs for weight loss are increasing their purchases of new clothing from retailers. Equity research firm Bernstein estimates this trend could generate up to $13 billion in annual spending for the apparel sector. The development highlights a gr…
Substrate placeholder — needs reviewfinance96 days ago
Apparel Retailers May See $13 Billion Annual Spending Increase from GLP-1 Weight Loss Drugs
Equity research firm Bernstein estimates that GLP-1 drugs, used by millions for weight loss, could drive up to $13 billion in additional annual spending at apparel retailers. Users of these medications are purchasing new clothing to fit their changed body sizes. The projection hi…
Substrate placeholder — needs reviewscience96 days ago
GLP-1 Weight Loss Drugs Prompt Retailers to Adjust for Changing Consumer Sizes
Tens of millions of Americans are using GLP-1 drugs that lead to rapid weight loss. This shift in body sizes is driving demand for new clothing. Retailers are adapting their inventories to meet the needs of these consumers.
sciencenews.orgscience97 days ago
Genomic and Demographic Data Enable Prediction of GLP-1 Drug Weight Loss Response
Researchers have identified that genomic and demographic data can predict the magnitude of weight loss from GLP-1 drugs. This approach involves analysis by 23andMe. The findings focus on drug response and side effects in obesity treatment.
ER
sciencenews.orgscience97 days ago
Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs
A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…
ST
neurosciencenews.comscience97 days ago
Genetic Variants Linked to Weight Loss Outcomes on GLP-1 Drugs in New Study
A study published in Nature identifies variations in two genes associated with greater weight loss and side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to 28,000 users, shows these genetic factors contribute modestly…
BU
ST
sciencenews.orgscience97 days ago
Genetic Variations in Two Genes Linked to Weight Loss and Side Effects from GLP-1 Drugs
Research indicates that variations in two genes associated with appetite and digestion can predict greater weight loss in patients using GLP-1 drugs for obesity treatment. These genetic changes also correlate with increased risk of nausea and vomiting as side effects. The finding…
ST